definitely still a risk but quite low. maybe some people are also true to the sell in may go away approach :/
for those interested there's a FDA study tracking 12 years of FDA NME applications (302) and FDA rejections (151 of 302) even of those receiving CRL for safety 62% were approved, for efficacy only 31% approved. and of thre original rejections labelling issues were only 15% of original rejection reason.
for the study the "drugs never approved" due to labelling was zero. this included labelling as a standalone (instructions) and labelling related to chemistry manufacturing and control
can't paste a link but if you search DOI 10.1001 / jama.2013.282542 the article is titled "Scientific and regulatory reasons for delay and denial of FDA approval for initial applications for new drugs, 2000-2012" with Sacks as primary author
- Forums
- ASX - By Stock
- BOT - Anything but charting
definitely still a risk but quite low. maybe some people are...
-
- There are more pages in this discussion • 2,286 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
42.3¢ |
Change
-0.003(0.59%) |
Mkt cap ! $780.0M |
Open | High | Low | Value | Volume |
43.0¢ | 43.3¢ | 42.3¢ | $777.3K | 1.812M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 429935 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 324523 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 429935 | 0.420 |
20 | 648078 | 0.415 |
13 | 498246 | 0.410 |
16 | 1635403 | 0.405 |
21 | 584075 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 324523 | 9 |
0.430 | 887761 | 8 |
0.435 | 572272 | 15 |
0.440 | 222890 | 9 |
0.445 | 333020 | 7 |
Last trade - 12.18pm 12/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |